SCHEMBL31665552

SCHEMBL31665552

Cc1cnc(NC(=O)c2ccc(N)cc2C)s1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 12/20 0.55
NPC1 O15118 11/20 0.55
MEN1 O00255 2/20 0.55
KMT2A Q03164 2/20 0.55
SMN1; SMN2 Q16637 6/20 0.54
ALDH1A1 P00352 4/20 0.54
MITF O75030 2/20 0.54
LMNA P02545 2/20 0.54
POLB P06746 2/20 0.53
PKM P14618 3/20 0.52
KDM4E B2RXH2 2/20 0.51
PAX8 Q06710 2/20 0.51
MAPK1 P28482 1/20 0.51
TP53 P04637 1/20 0.51
MAPT P10636 1/20 0.51
HPGD P15428 1/20 0.51
TDP1 Q9NUW8 1/20 0.51
GCK P35557 1/20 0.48
CSNK2A2 P19784 1/20 0.48
CSNK2B P67870 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31110024 0.85 SMN1; SMN2 (0.56) RAB9ANPC1MEN1KMT2ASMN1; SMN2
SCHEMBL24072749 0.85 STAT3 (0.41) RAB9ANPC1MEN1KMT2ASMN1; SMN2
SCHEMBL25142712 0.84 RAB9A (0.55) RAB9ANPC1MEN1KMT2ASMN1; SMN2
SCHEMBL25142552 0.84 RAB9A (0.52) RAB9ANPC1MEN1KMT2ASMN1; SMN2
SCHEMBL31665212 0.84 RAB9A (0.55) RAB9ANPC1MEN1KMT2ASMN1; SMN2
SCHEMBL27134453 0.84 RAB9A (0.59) RAB9ANPC1MEN1KMT2ASMN1; SMN2
SCHEMBL25142778 0.84 SMN1; SMN2 (0.57) RAB9ANPC1MEN1KMT2ASMN1; SMN2
SCHEMBL25142518 0.84 RAB9A (0.55) RAB9ANPC1MEN1KMT2ASMN1; SMN2
SCHEMBL27134454 0.84 RAB9A (0.60) RAB9ANPC1MEN1KMT2ASMN1; SMN2
SCHEMBL4290502 0.83 SMN1; SMN2 (0.71) RAB9ANPC1MEN1KMT2ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250235543-A1 MODIFIED PROTEINS AND PROTEIN DEGRADERS CULLGEN (SHANGHAI), INC. (CN) 2025-07-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250235543-A1 MODIFIED PROTEINS AND PROTEIN DEGRADERS DDB1, DCLRE1A, TP53BP1 RAB9A 3234/4885NPC1 3357/4885MEN1 2854/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.